M&T Bank’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-1,542
Closed -$233K – 1631
2019
Q1
$233K Buy
+1,542
New +$222K ﹤0.01% 1328
2018
Q4
– Sell
-1,765
Closed -$280K – 1469
2018
Q3
$280K Buy
+1,765
New +$267K ﹤0.01% 1268
2016
Q1
– Sell
-4,212
Closed -$476K – 1751
2015
Q4
$476K Buy
4,212
+358
+9% +$38.5K ﹤0.01% 1087
2015
Q3
$390K Buy
3,854
+582
+18% +$69.2K ﹤0.01% 1183
2015
Q2
$406K Buy
3,272
+354
+12% +$42.7K ﹤0.01% 1327
2015
Q1
$345K Sell
2,918
-19
-0.6% -$2.15K ﹤0.01% 1363
2014
Q4
$300K Buy
2,937
+96
+3% +$9.38K ﹤0.01% 1485
2014
Q3
$261K Buy
+2,841
New +$246K ﹤0.01% 1671

Other funds holding FBT

M&T Bank's FBT Position: Q2 2019 in Review

M&T Bank sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2019, closing a stake of 1,542 shares — an estimated $233K sold.

M&T Bank first reported a position in FBT in Q3 2014 and held it in 8 quarters. The position peaked at $476K in Q4 2015. 222 funds tracked by Wall St. Rank hold FBT as of Q2 2019.

  • M&T Bank reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2019 after selling out during the quarter.
  • M&T Bank sold 1,542 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2019, an estimated $233K.
  • M&T Bank first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2014 and held it in 8 quarters.
  • M&T Bank's First Trust NYSE Arca Biotechnology Index Fund position peaked at $476K in Q4 2015.
  • 222 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2019.

Based on M&T Bank's 13F filing for Q2 2019, filed 12 Aug 2019.